» Articles » PMID: 10188003

The Calcium Response of Human T Lymphocytes is Decreased in Aging but Increased in Alzheimer's Dementia

Overview
Journal Biol Psychiatry
Publisher Elsevier
Specialty Psychiatry
Date 1999 Apr 3
PMID 10188003
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A significant increase in the [Ca2+]i response of single T lymphocytes to mitogenic stimulation with phytohemagglutinin is reported for 27 Alzheimer patients compared with 27 healthy gender- and age-matched control subjects, regardless of gender.

Methods: The [Ca2+]i signals of T lymphocytes were assessed using the Fura-2-AM method.

Results: In Alzheimer's disease (AD) the reaction pattern is similar to that seen in a group of 27 young healthy control subjects who exhibited a marked [Ca2+]i rise after stimulation. During normal aging the reaction pattern of T cells is significantly attenuated in comparison to that found in young subjects. In healthy control subjects differences in age-related changes in calcium homeostasis are highly significant among women, young women showing the most intense cell response.

Conclusions: The elevation of [Ca2+]i appears to be a prerequisite for apoptosis, which is suggested to be involved in the neuronal death occurring in AD. An increased [Ca2+]i in AD is consistent with processes leading to neurodegeneration in AD.

Citing Articles

Insights into T-cell dysfunction in Alzheimer's disease.

Dai L, Shen Y Aging Cell. 2021; 20(12):e13511.

PMID: 34725916 PMC: 8672785. DOI: 10.1111/acel.13511.


On the Role of Store-Operated Calcium Entry in Acute and Chronic Neurodegenerative Diseases.

Secondo A, Bagetta G, Amantea D Front Mol Neurosci. 2018; 11:87.

PMID: 29623030 PMC: 5874322. DOI: 10.3389/fnmol.2018.00087.


Calcium Dynamics of Ex Vivo Long-Term Cultured CD8+ T Cells Are Regulated by Changes in Redox Metabolism.

Rivet C, Kniss-James A, Gran M, Potnis A, Hill A, Lu H PLoS One. 2016; 11(8):e0159248.

PMID: 27526200 PMC: 4985122. DOI: 10.1371/journal.pone.0159248.


Immunomodulation by memantine in therapy of Alzheimer's disease is mediated through inhibition of Kv1.3 channels and T cell responsiveness.

Lowinus T, Bose T, Busse S, Busse M, Reinhold D, Schraven B Oncotarget. 2016; 7(33):53797-53807.

PMID: 27462773 PMC: 5288222. DOI: 10.18632/oncotarget.10777.


Overexpression of Cell Cycle Proteins of Peripheral Lymphocytes in Patients with Alzheimer's Disease.

Kim H, Kwon Y, Ahn I, Kim S, Kim S, Jo S Psychiatry Investig. 2016; 13(1):127-34.

PMID: 26766955 PMC: 4701676. DOI: 10.4306/pi.2016.13.1.127.